Evidence map›Paper›PMID 30914695›Full record

ArticleScientific reports2019

The M

Panagiotis Laspas, Mayagozel B Zhutdieva, Christoph Brochhausen, Aytan Musayeva, Jenia Kouchek Zadeh, Norbert Pfeiffer, Ning Xia, Huige Li, Juergen Wess, Adrian Gericke

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Retinal Neurodegeneration in an Intraocular Pressure Fluctuation Rat Model.International journal of molecular sciences · 2024
    Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Immunomodulatory and Antioxidant Drugs in Glaucoma Treatment.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Muscarinic Acetylcholine Receptors in the Retina-Therapeutic Implications.International journal of molecular sciences · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Panagiotis LaspasDepartment of Ophthalmology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany. panagiotis.laspas@unimedizin-mainz.de.ORCID 0000-0001-8022-9494
Mayagozel B ZhutdievaDepartment of Ophthalmology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.
Christoph BrochhausenInstitute of Pathology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.
Aytan MusayevaDepartment of Ophthalmology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.
Jenia Kouchek ZadehDepartment of Ophthalmology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.
Norbert PfeifferDepartment of Ophthalmology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.
Ning XiaInstitute of Pharmacology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.
Huige LiInstitute of Pharmacology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.ORCID 0000-0003-3458-7391
Juergen WessMolecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Adrian GerickeDepartment of Ophthalmology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.
Johannes Gutenberg University Mainz · DENational Institutes of Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Muscarinic acetylcholine receptors have been implicated as potential neuroprotective targets for glaucoma. We tested the hypothesis that the lack of a single muscarinic receptor subtype leads to age-dependent neuron reduction in the retinal ganglion cell layer. Mice with targeted disruption of single muscarinic acetylcholine receptor subtype genes (M

Indexed as

AgingAnimalsCell SurvivalEye ProteinsGene Expression Regulation, EnzymologicMiceMice, KnockoutOxidoreductasesReceptor, Muscarinic M1Retinal Ganglion CellsEye ProteinsOxidoreductasesReceptor, Muscarinic M1

Identifiers

PMID30914695
PMCPMC6435680
OpenAlexW2923010297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.